Riskpilot← Back to searchSign inGet full accessEMPET KLØFTA DYREKLINIKK AS
ASActiveOrg 928792455Kongsvingervegen 6, 2040 KløftaVeterinary activities · NACE 7500Est. 20228 employees
Revenue 2024
NOK 8,7M
+12% vs 2023
EBITDA margin
20.5%
+21% vs 2023
Equity ratio
55.8%
Financial strength
Net profit 2024
NOK 1,4M
+24% vs 2023
| Revenue | NOK 8,7M | +12% |
| EBITDA | NOK 1,8M | +21% |
| Net profit | NOK 1,4M | +24% |
| Total assets | NOK 6,9M | +10% |
| Equity | NOK 3,8M | -1% |
| Employees | 8 | — |
Legal name
EMPET KLØFTA DYREKLINIKK AS
Org number
928792455
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
23. februar 2022
Share capital
NOK 124 800
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drive veterinærvirksomhet og annen virksomhet som står i forbindelse med dette.
Address
Kongsvingervegen 6, 2040 Kløfta
Phone
+4763936400
Email
post@dinvet.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 7 505 | 7 774 | 8 703 |
| Staff expenses | −3 720 | −3 593 | −4 000 |
| EBITDA | 1 293 | 1 475 | 1 783 |
| Depreciation & amort. | −133 | −295 | −312 |
| EBIT | 1 160 | 1 180 | 1 472 |
| Net financials | 58 | 233 | 277 |
| Profit before tax | 1 218 | 1 413 | 1 749 |
| Tax | 294 | 311 | 385 |
| Net profit | 924 | 1 102 | 1 364 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 6 090 | 6 223 | 6 856 |
| Equity | 3 859 | 3 846 | 3 823 |
| Long-term debt | 27 | 23 | 17 |
| Short-term debt | 2 205 | 2 353 | 3 016 |
| Total debt | 2 232 | 2 376 | 3 032 |
EBITDA margin
20.5%
This company
15.8%
Market median
+30% vs market
20222024
Equity ratio
55.8%
This company
38.2%
Market median
+46% vs market
20222024
Return on equity
35.7%
This company
18.4%
Market median
+94% vs market
20222024
Net profit margin
15.7%
This company
8.1%
Market median
+94% vs market
20222024
Asset turnover
1.27×
This company
1.12×
Market median
+13% vs market
20222024
Debt / equity
0.79×
This company
0.62×
Market median
+27% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LØ Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
CB Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Former (1) | ||
| Chairman | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ax Vi Vet No Holding As
EMPET KLØFTA DYREKLINIKK AS Board members of EMPET KLØFTA DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cathrine Berget | Chief Executive Officer | 0 companies |
| Lisa Østgård Breivik | Chief Executive Officer | 0 companies |
| Eirik Nilssen | Chairman | 0 companies |
| Karin Jenny Rønneberg | Chairman | 0 companies |